Latest Insider Transactions at Eagle Pharmaceuticals, Inc. (EGRX)
This section provides a real-time view of insider transactions for Eagle Pharmaceuticals, Inc. (EGRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EAGLE PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EAGLE PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 23
2021
|
David Pernock Pres & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,892
-4.04%
|
$88,924
$47.7 P/Share
|
|
Jan 07
2021
|
David Pernock Pres & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
906
-1.9%
|
$45,300
$50.97 P/Share
|
|
Jan 07
2021
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
237
-1.63%
|
$11,850
$50.97 P/Share
|
|
Jan 05
2021
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
746
-4.88%
|
$37,300
$50.02 P/Share
|
|
Jan 05
2021
|
David Pernock Pres & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,088
-4.19%
|
$104,400
$50.02 P/Share
|
|
Dec 18
2020
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+20.57%
|
-
|
|
Feb 28
2020
|
Steven B Ratoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,340
+10.32%
|
$18,720
$8.78 P/Share
|
|
Oct 25
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
15,437
-2.06%
|
$972,531
$63.57 P/Share
|
|
Oct 24
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
1,494
-0.2%
|
$92,628
$62.53 P/Share
|
|
Oct 23
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
200
-0.03%
|
$12,400
$62.58 P/Share
|
|
Oct 22
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
6,567
-0.87%
|
$407,154
$62.68 P/Share
|
|
Oct 21
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
3,849
-0.51%
|
$238,638
$62.56 P/Share
|
|
Oct 18
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
1,600
-0.21%
|
$99,200
$62.61 P/Share
|
|
Oct 17
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
13,842
-1.78%
|
$858,204
$62.58 P/Share
|
|
Oct 16
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
102
-0.01%
|
$6,324
$62.5 P/Share
|
|
Oct 15
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
3,909
-0.5%
|
$242,358
$62.63 P/Share
|
|
Oct 11
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
16,300
-2.05%
|
$978,000
$60.39 P/Share
|
|
Oct 10
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
7,829
-0.97%
|
$469,740
$60.16 P/Share
|
|
Oct 08
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
1,558
-0.19%
|
$93,480
$60.03 P/Share
|
|
Oct 07
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
4,901
-0.6%
|
$294,060
$60.11 P/Share
|
|
Sep 17
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
100
-0.01%
|
$6,000
$60.0 P/Share
|
|
Sep 12
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
200
-0.02%
|
$12,000
$60.07 P/Share
|
|
Sep 11
2019
|
Hudson Executive Capital LP Director |
SELL
Open market or private sale
|
Indirect |
1,112
-0.14%
|
$66,720
$60.06 P/Share
|